Core Insights - The return of dividend-type critical illness insurance to the market is supported by regulatory guidance aimed at enhancing the attractiveness of health insurance products and addressing the challenges posed by declining preset interest rates [1][3]. Industry Overview - The Financial Regulatory Authority has issued guidelines to promote high-quality development in health insurance, allowing well-rated insurance companies to offer dividend-type long-term health insurance products [1]. - Dividend-type critical illness insurance was popular in the early 2000s but was phased out due to regulatory concerns over complexity and mis-selling [2]. Market Dynamics - Analysts suggest that the reintroduction of dividend-type critical illness insurance can stimulate industry growth by providing a floating income mechanism that enhances product appeal [1][3]. - The current insurance market faces challenges such as intense competition and the need for product differentiation, which dividend insurance can address by offering dynamic coverage that adjusts for inflation [3]. Challenges Ahead - The successful re-entry of dividend-type critical illness insurance will require balancing protection and dividend features, which poses significant actuarial and risk management challenges for insurance companies [5]. - The higher premiums associated with dividend-type products compared to traditional insurance may complicate sales efforts, necessitating clear communication about the uncertainties of dividends to avoid consumer disputes [5]. Strategic Recommendations - Insurance companies are advised to enhance transparency in dividend mechanisms, improve agent training, and leverage big data for pricing optimization to increase product value [5][6]. - The importance of agent channels is emphasized, as they play a crucial role in educating consumers about complex insurance products and matching them with suitable options [6]. Regulatory Developments - The regulatory body plans to expedite the development of supporting guidelines for floating income health insurance products, encouraging insurance companies to diversify their offerings to meet public demand for quality health coverage [6].